Trials / Completed
CompletedNCT00466180
Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Taking antiretrovirals once-a-day is considered the simpler way to improve adherence. However, it is not know if this assertion apply to patients taking their medication twice-a-day who change to once-a-day. We hypothesized that once-daily dosing improves adherence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Nevirapine from twice-a-day to once-a-day |
Timeline
- Start date
- 2004-06-01
- Completion
- 2006-11-01
- First posted
- 2007-04-27
- Last updated
- 2010-10-28
Source: ClinicalTrials.gov record NCT00466180. Inclusion in this directory is not an endorsement.